Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

HIV is currently the only disease carrying a felony charge if someone knowingly transmits it to another person. The Senate ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

A patient told MassLive she was horrified to receive a phone call from her surgeon post-operation saying she should be tested for bloodborne pathogens.

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...